Dr. Christina Annunziata of the American Cancer Society breaks down the latest cancer advances: new multi-cancer blood tests that can detect cancers earlier (including types we currently can’t screen for), why these tests are complementary to — not replacements for — standard screening, and how targeted therapies (like treatments for RET-mutated lung cancer) are extending survival. She also explains the impact of prevention (HPV vaccine for cervical cancer) and why continued research and equitable access are critical to making these breakthroughs benefit everyone.